Featured Clinical Focus

AML Biomarker-Driven Lung Cancer Bone Marrow & SCT BTK Inhibitors: In-Focus CAR T-Cell Therapy Chronic Lymphocytic Leukemia EGFR-Positive Lung Cancer Endometrial Cancer Follicular Lymphoma HCC Lung Cancer Mantle Cell Lymphoma MPNs Multiple Myeloma Renal Cell Carcinoma Small Cell Lung Cancer Thyroid Cancers

AML Biomarker-Driven Lung Cancer Bone Marrow & SCT BTK Inhibitors: In-Focus CAR T-Cell Therapy Chronic Lymphocytic Leukemia EGFR-Positive Lung Cancer Endometrial Cancer Follicular Lymphoma HCC Lung Cancer Mantle Cell Lymphoma MPNs Multiple Myeloma Renal Cell Carcinoma Small Cell Lung Cancer Thyroid Cancers

View More Brain Cancer Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Cancers Head & Neck Cancers Hematology Leukemias Lung Cancer Lymphomas Melanoma Sarcoma Skin Cancers Thyroid Cancers

Brain Cancer Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Cancers Head & Neck Cancers Hematology Leukemias Lung Cancer Lymphomas Melanoma Sarcoma Skin Cancers Thyroid Cancers

All News Special Reports

Conference Coverage Conference Listing

All Videos Case-Based Peer Perspectives Expert Perspective Virtual Tumor Board Interviews Investigator Perspectives Medical World News Podcasts Precision Medicine

All Videos Case-Based Peer Perspectives Expert Perspective Virtual Tumor Board Interviews Investigator Perspectives Medical World News Podcasts Precision Medicine

All Publications Evolving Paradigms Roundtable Meetings Spotlight Targeted Therapies in Oncology

All Publications Evolving Paradigms Roundtable Meetings Spotlight Targeted Therapies in Oncology

Case-Based Roundtable Series Clinical Trials Partners Precision Medicine Perspectives Press Releases Treatment Resources

Case-Based Roundtable Series Clinical Trials Partners Precision Medicine Perspectives Press Releases Treatment Resources

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions

© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Featured Clinical Focus

AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers

Clinical FocusSee All >

Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions

© 2022 MJH Life Sciences^™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

A 68-Year-Old Man With Gastrointestinal Stromal Tumor

Margaret von Mehren, MD, describes the rationale for treating a man with GIST with ripretinib as fourth-line therapy.

EP. 1: Case Overview: A 68-Year-Old Man With GIST

June 22nd 2020

EP. 2: GIST Diagnoses and Risk of Recurrence

June 22nd 2020

EP. 3: GIST: Treatment Considerations

June 22nd 2020

EP. 4: GIST: Second-Line Treatment Options

June 22nd 2020

EP. 5: Resistance to TKI Therapies in GIST

June 22nd 2020

EP. 6: GIST: Third-Line Treatment Considerations

June 22nd 2020

EP. 7: The INVICTUS Trial in GIST

June 22nd 2020

EP. 8: Safety and Efficacy of a Newer TKI for Fourth-Line GIST

June 22nd 2020

EP. 9: GIST: Treating With Ripretinib

June 22nd 2020

EP. 10: Utilizing Newer TKIs to Treat GIST

June 22nd 2020